GSK3B and neoplasm: Taken together, these data demonstrated that CB reduced MYH9 via regulating PI3K/AKT/Myc/P53/miR-133a-3p, which then increased GSK3β expression to antagonize β-catenin-activated tumor stemness and EMT signals.